Cargando…
Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients
Intratumoral heterogeneity of breast cancer remains a major challenge in successful treatment. Failure of cancer therapies can also be accredited to inability to systemically eradicate cancer stem cells (CSCs). Recent evidence points to the role of epithelial-mesenchymal transition (EMT) in expandin...
Autores principales: | Markiewicz, Aleksandra, Nagel, Anna, Szade, Jolanta, Majewska, Hanna, Skokowski, Jaroslaw, Seroczynska, Barbara, Stokowy, Tomasz, Welnicka-Jaskiewicz, Marzena, Zaczek, Anna J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6056759/ https://www.ncbi.nlm.nih.gov/pubmed/29660692 http://dx.doi.org/10.1016/j.tranon.2018.03.006 |
Ejemplares similares
-
Heterogeneity of Mesenchymal Markers Expression—Molecular Profiles of Cancer Cells Disseminated by Lymphatic and Hematogenous Routes in Breast Cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2013) -
Mesenchymal Phenotype of CTC-Enriched Blood Fraction and Lymph Node Metastasis Formation Potential
por: Markiewicz, Aleksandra, et al.
Publicado: (2014) -
Spectrum of Epithelial-Mesenchymal Transition Phenotypes in Circulating Tumour Cells from Early Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2019) -
Expression of epithelial to mesenchymal transition-related markers in lymph node metastases as a surrogate for primary tumor metastatic potential in breast cancer
por: Markiewicz, Aleksandra, et al.
Publicado: (2012) -
Prognostic Significance of ESR1 Amplification and ESR1 PvuII, CYP2C19*2, UGT2B15*2 Polymorphisms in Breast Cancer Patients
por: Markiewicz, Aleksandra, et al.
Publicado: (2013)